2513. CERTAIN-1 Subgroup Analysis: A Phase 3 Study of Cefepime-Taniborbactam Efficacy in the Treatment of Complicated Urinary Tract Infections (cUTI)

BACKGROUND: Cefepime-taniborbactam (FTB) is an investigational β-lactam/β-lactamase inhibitor combination that is active against carbapenem-resistant Enterobacterales and multidrug resistant Pseudomonas aeruginosa expressing serine and metallo-β-lactamases. CERTAIN-1 (Cefepime Rescue with Taniborbac...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorr, Mary Beth, Gasink, Leanne, Henkel, Tim, Moeck, Greg, Chen, Hongzi, McConnell, Scott A, McGovern, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678857/
http://dx.doi.org/10.1093/ofid/ofad500.2131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678857/
http://dx.doi.org/10.1093/ofid/ofad500.2131

Ejemplares similares